177Lu-DOTATATE Plus 166Ho-Radioembolization in Patients with Neuroendocrine Tumours; A Single Center, Prospective, Interventional, Non-Comparative, Open Label, Phase II Study (HEPAR PLuS Study)

A. Braat; R. Van Rooij; Rutger Bruijnen; M. Braat; F. Wessels; R. van Leeuwaarde; M. van Treijen; H. de Jong; M. Lam

doi:10.1093/annonc/mdz256

177Lu-DOTATATE Plus 166Ho-Radioembolization in Patients with Neuroendocrine Tumours; A Single Center, Prospective, Interventional, Non-Comparative, Open Label, Phase II Study (HEPAR PLuS Study)

A. Braat
, R. Van Rooij
, Rutger Bruijnen
, M. Braat
, F. Wessels
, R. van Leeuwaarde
, M. van Treijen
, H. de Jong
, M. Lam

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	249-249
Journal	Neuroendocrinology
Volume	110
DOIs	https://doi.org/10.1093/annonc/mdz256
Publication status	Published - Mar 2020

Keywords

net
prrt
sirt
radioembolization
ho-166
neuroendocrine tumor

Access to Document

10.1093/annonc/mdz256

Cite this

Braat, A., Van Rooij, R., Bruijnen, R., Braat, M., Wessels, F., van Leeuwaarde, R., van Treijen, M., de Jong, H., & Lam, M. (2020). 177Lu-DOTATATE Plus 166Ho-Radioembolization in Patients with Neuroendocrine Tumours; A Single Center, Prospective, Interventional, Non-Comparative, Open Label, Phase II Study (HEPAR PLuS Study). Neuroendocrinology, 110, 249-249. https://doi.org/10.1093/annonc/mdz256

@article{93042c8cc47a4aa2b92249bf56a0c461,

title = "177Lu-DOTATATE Plus 166Ho-Radioembolization in Patients with Neuroendocrine Tumours; A Single Center, Prospective, Interventional, Non-Comparative, Open Label, Phase II Study (HEPAR PLuS Study)",

keywords = "net, prrt, sirt, radioembolization, ho-166, neuroendocrine tumor",

author = "A. Braat and \{Van Rooij\}, R. and Rutger Bruijnen and M. Braat and F. Wessels and \{van Leeuwaarde\}, R. and \{van Treijen\}, M. and \{de Jong\}, H. and M. Lam",

year = "2020",

month = mar,

doi = "10.1093/annonc/mdz256",

language = "English",

volume = "110",

pages = "249--249",

journal = "Neuroendocrinology",

issn = "0028-3835",

publisher = "S. Karger AG",

}

Braat, A, Van Rooij, R, Bruijnen, R, Braat, M, Wessels, F, van Leeuwaarde, R, van Treijen, M, de Jong, H & Lam, M 2020, '177Lu-DOTATATE Plus 166Ho-Radioembolization in Patients with Neuroendocrine Tumours; A Single Center, Prospective, Interventional, Non-Comparative, Open Label, Phase II Study (HEPAR PLuS Study)', Neuroendocrinology, vol. 110, pp. 249-249. https://doi.org/10.1093/annonc/mdz256

177Lu-DOTATATE Plus 166Ho-Radioembolization in Patients with Neuroendocrine Tumours; A Single Center, Prospective, Interventional, Non-Comparative, Open Label, Phase II Study (HEPAR PLuS Study). / Braat, A.; Van Rooij, R.; Bruijnen, Rutger et al.
In: Neuroendocrinology, Vol. 110, 03.2020, p. 249-249.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - 177Lu-DOTATATE Plus 166Ho-Radioembolization in Patients with Neuroendocrine Tumours; A Single Center, Prospective, Interventional, Non-Comparative, Open Label, Phase II Study (HEPAR PLuS Study)

AU - Braat, A.

AU - Van Rooij, R.

AU - Bruijnen, Rutger

AU - Braat, M.

AU - Wessels, F.

AU - van Leeuwaarde, R.

AU - van Treijen, M.

AU - de Jong, H.

AU - Lam, M.

PY - 2020/3

Y1 - 2020/3

KW - net

KW - prrt

KW - sirt

KW - radioembolization

KW - ho-166

KW - neuroendocrine tumor

U2 - 10.1093/annonc/mdz256

DO - 10.1093/annonc/mdz256

M3 - Meeting Abstract

SN - 0028-3835

VL - 110

SP - 249

EP - 249

JO - Neuroendocrinology

JF - Neuroendocrinology

ER -